by Sabina S Alistar, Philip M Grant and Eran Bendavid
BMC Medicine 2014, 12:46 (17 March 2014)
11 pp. 5.5 MB:
Antiretroviral therapy (ART) and oral pre-exposure prophylaxis (PrEP) are effective in reducing HIV transmission in heterosexual adults. The epidemiologic impact and cost-effectiveness of combined prevention approaches in resource-limited settings remain unclear. The authors conclude that expanded ART coverage to individuals in early disease stages may be more cost-effective than current guidelines. PrEP can be cost-saving if delivered to individuals at increased risk of infection.